公开(公告)号：US20180078532A1

公开(公告)日：2018-03-22

申请号：US15707005

申请日：2017-09-18

Applicant: AMGEN INC.

Inventor： John Inn CHUNG ,  Armen PIRJANIAN ,  Fernando ALVAREZ-NUNEZ ,  Jeffrey Michael KATZ ,  Dominick DAURIO

IPC: A61K31/426 ,  A61K47/02 ,  A61K47/38 ,  A61K47/12 ,  A61K9/20 ,  A61K9/28

CPC classification number: A61K31/426 ,  A61K9/0053 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/28 ,  A61K9/284 ,  A61K38/06 ,  A61K47/02 ,  A61K47/12 ,  A61K47/38

Abstract: This disclosure features immediate release pharmaceutical formulations (e.g., solid dosage forms, e.g., tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to a human or animal subject as well as methods of making and using the formulations.